Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 4954

1.

Clinical Profiles of DFNA11 at Diverse Stages of Development and Aging in a Large Family Identified by Linkage Analysis.

Yamamoto N, Mutai H, Namba K, Goto F, Ogawa K, Matsunaga T.

Otol Neurotol. 2020 Feb 25. doi: 10.1097/MAO.0000000000002604. [Epub ahead of print]

PMID:
32097363
2.

Field localization of hexagonal and short-range ordered plasmonic nanoholes investigated by cathodoluminescence.

Vu Thi D, Ohno T, Yamamoto N, Sannomiya T.

J Chem Phys. 2020 Feb 21;152(7):074707. doi: 10.1063/1.5131698.

PMID:
32087626
3.

Dynamic change in the distribution of cancer types in oncology phase I trials.

Sato J, Itahashi K, Shimizu T, Koyama T, Kondo S, Fujiwara Y, Yamamoto N.

Ann Oncol. 2019 Feb;30 Suppl 1:i12. doi: 10.1093/annonc/mdz026.001. Epub 2020 Jan 8. No abstract available.

4.

Number of metastatic organs negatively affects the treatment sequence in patients with EGFR-TKI failure.

Mizuno T, Horinouchi H, Watanabe S, Sato J, Morita R, Murakami S, Goto Y, Kanda S, Fujiwara Y, Yamamoto N, Ohe Y.

Thorac Cancer. 2020 Feb 20. doi: 10.1111/1759-7714.13360. [Epub ahead of print]

5.

VEGF and bFGF induction by nitric oxide is associated with hyperbaric oxygen-induced angiogenesis and muscle regeneration.

Yamamoto N, Oyaizu T, Enomoto M, Horie M, Yuasa M, Okawa A, Yagishita K.

Sci Rep. 2020 Feb 17;10(1):2744. doi: 10.1038/s41598-020-59615-x.

6.

Propensity score-weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non-small cell lung cancer (WJOG10217L).

Kato R, Hayashi H, Chiba Y, Miyawaki E, Shimizu J, Ozaki T, Fujimoto D, Toyozawa R, Nakamura A, Kozuki T, Tanaka K, Teraoka S, Usui K, Nishino K, Hataji O, Ota K, Ebi N, Saeki S, Akazawa Y, Okuno M, Yamamoto N, Nakagawa K.

J Immunother Cancer. 2020 Feb;8(1). pii: e000350. doi: 10.1136/jitc-2019-000350.

7.

Polypoid gallbladder neuroendocrine tumor diagnosed as benign polyp before surgery: A case report.

Naito S, Naito M, Yamamoto N, Kume T, Hosino S, Kinjyo Y, Naito Y, Naito H, Hasegawa S.

Mol Clin Oncol. 2020 Mar;12(3):225-229. doi: 10.3892/mco.2019.1971. Epub 2019 Dec 24.

8.

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.

Yamashiro H, Iwata H, Masuda N, Yamamoto N, Nishimura R, Ohtani S, Sato N, Takahashi M, Kamio T, Yamazaki K, Saito T, Kato M, Lee T, Kuroi K, Takano T, Yasuno S, Morita S, Ohno S, Toi M; JBCRG-C01 Collaborative Group.

Breast Cancer. 2020 Feb 14. doi: 10.1007/s12282-020-01057-4. [Epub ahead of print]

PMID:
32060785
9.

Imaging-guided PCI for event suppression in Japanese acute coronary syndrome patients: community-based observational cohort registry.

Yamashita T, Sakamoto K, Tabata N, Ishii M, Sato R, Nagamatsu S, Motozato K, Yamanaga K, Sueta D, Araki S, Arima Y, Yamamoto E, Takashio S, Fujisue K, Fujimoto K, Shimomura H, Tsunoda R, Maruyama H, Nakamura N, Sakaino N, Nakamura S, Yamamoto N, Matsumura T, Kajiwara I, Tayama S, Sakamoto T, Nakao K, Oshima S, Kaikita K, Hokimoto S, Tsujita K; Kumamoto Intervention Conference Study (KICS) Investigators.

Cardiovasc Interv Ther. 2020 Feb 12. doi: 10.1007/s12928-020-00649-3. [Epub ahead of print]

PMID:
32052349
10.

Desloratadine inhibits heterotopic ossification by suppression of BMP2-Smad1/5/8 signaling.

Kusano T, Nakatani M, Ishiguro N, Ohno K, Yamamoto N, Morita M, Yamada H, Uezumi A, Tsuchida K.

J Orthop Res. 2020 Feb 11. doi: 10.1002/jor.24625. [Epub ahead of print]

PMID:
32043642
11.

Effect of transcatheter arterial embolisation in normal canine liver using trisacryl gelatine microspheres (Embosphere).

Nakasumi K, Sunahara H, Igari K, Itoh H, Itamoto K, Yamamoto N, Ishikawa T, Takami T, Sakaida I, Taura Y, Tani K.

Res Vet Sci. 2020 Jan 23;129:174-177. doi: 10.1016/j.rvsc.2020.01.018. [Epub ahead of print]

PMID:
32036125
12.

The Intravitreal Injection of Lanosterol Nanoparticles Rescues Lens Structure Collapse at an Early Stage in Shumiya Cataract Rats.

Nagai N, Fukuoka Y, Sato K, Otake H, Taga A, Oka M, Hiramatsu N, Yamamoto N.

Int J Mol Sci. 2020 Feb 5;21(3). pii: E1048. doi: 10.3390/ijms21031048.

13.

Pedicle frozen autograft-prosthesis composite reconstructions for malignant bone tumors of the proximal femur.

Xu G, Miwa S, Yamamoto N, Hayashi K, Takeuchi A, Igarashi K, Higuchi T, Taniguchi Y, Araki Y, Yonezawa H, Morinaga S, Tsuchiya H.

BMC Musculoskelet Disord. 2020 Feb 6;21(1):81. doi: 10.1186/s12891-020-3112-0.

14.

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy.

Tokudome N, Koh Y, Akamatsu H, Fujimoto D, Okamoto I, Nakagawa K, Hida T, Imamura F, Morita S, Yamamoto N.

BMC Cancer. 2020 Feb 6;20(1):103. doi: 10.1186/s12885-020-6593-1.

15.

Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study.

Takahama T, Azuma K, Shimokawa M, Takeda M, Ishii H, Kato T, Saito H, Daga H, Tsuboguchi Y, Okamoto I, Otsubo K, Akamatsu H, Teraoka S, Takahashi T, Ono A, Ohira T, Yokoyama T, Sakai K, Yamamoto N, Nishio K, Nakagawa K.

Cancer. 2020 Feb 5. doi: 10.1002/cncr.32749. [Epub ahead of print]

PMID:
32022929
16.

Oral intake of α‑glucosyl‑hesperidin ameliorates selenite‑induced cataract formation.

Nakazawa Y, Aoki M, Ishiwa S, Morishita N, Endo S, Nagai N, Yamamoto N, Funakoshi-Tago M, Tamura H.

Mol Med Rep. 2020 Mar;21(3):1258-1266. doi: 10.3892/mmr.2020.10941. Epub 2020 Jan 14.

17.

Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system.

Ikeda M, Koh Y, Teraoka S, Sato K, Kanai K, Hayata A, Tokudome N, Akamatsu H, Ozawa Y, Akamatsu K, Endo K, Higuchi M, Nakanishi M, Ueda H, Yamamoto N.

Cancer Med. 2020 Jan 30. doi: 10.1002/cam4.2846. [Epub ahead of print]

18.

Difficult-to-Detect Staphylococcus aureus: mecA-positive Isolates Associated with Oxacillin and Cefoxitin False-Susceptible Results.

Gargis AS, Yoo BB, Lonsway DR, Anderson K, Campbell D, Ewing T, Lawsin A, Machado MJ, Yamamoto N, Halpin AL, Lutgring JD, Karlsson M, Rasheed JK, Elkins CA.

J Clin Microbiol. 2020 Jan 29. pii: JCM.02038-19. doi: 10.1128/JCM.02038-19. [Epub ahead of print]

PMID:
31996449
19.

In Vitro Efficacy of Meropenem-Cefmetazole Combination Therapy against New Delhi Metallo-β-lactamase-producing Enterobacteriaceae.

Hagiya H, Sugawara Y, Tsutsumi Y, Akeda Y, Yamamoto N, Sakamoto N, Shanmugakani RK, Abe R, Takeuchi D, Nishi I, Ishii Y, Hamada S, Tomono K.

Int J Antimicrob Agents. 2020 Jan 25:105905. doi: 10.1016/j.ijantimicag.2020.105905. [Epub ahead of print]

PMID:
31991221
20.

Prediction of Pulmonary to Systemic Flow Ratio in Patients With Congenital Heart Disease Using Deep Learning-Based Analysis of Chest Radiographs.

Toba S, Mitani Y, Yodoya N, Ohashi H, Sawada H, Hayakawa H, Hirayama M, Futsuki A, Yamamoto N, Ito H, Konuma T, Shimpo H, Takao M.

JAMA Cardiol. 2020 Jan 22. doi: 10.1001/jamacardio.2019.5620. [Epub ahead of print]

PMID:
31968049
21.

Randomized phase II study of chemoradiotherapy with cisplatin + S-1 versus cisplatin + pemetrexed for locally advanced non-squamous non-small cell lung cancer: SPECTRA study.

Niho S, Yoshida T, Akimoto T, Sakamaki K, Ono A, Seto T, Nishio M, Yamamoto N, Hida T, Okamoto H, Kurata T, Satouchi M, Goto K, Yamanaka T, Ohe Y.

Lung Cancer. 2020 Mar;141:64-71. doi: 10.1016/j.lungcan.2020.01.008. Epub 2020 Jan 10.

PMID:
31955002
22.

Draft Genome Sequence of Rhodococcus aetherivorans JCM 14343T, a Bacterium Capable of Degrading Recalcitrant Noncyclic and Cyclic Ethers.

Inoue D, Nakazawa M, Yamamoto N, Sei K, Ike M.

Microbiol Resour Announc. 2020 Jan 16;9(3). pii: e01345-19. doi: 10.1128/MRA.01345-19.

23.

Catalytic Atroposelective Synthesis of N-Aryl Quinoid Compounds.

Vaidya SD, Toenjes ST, Yamamoto N, Maddox SM, Gustafson JL.

J Am Chem Soc. 2020 Feb 5;142(5):2198-2203. doi: 10.1021/jacs.9b12994. Epub 2020 Jan 28.

PMID:
31944689
24.

Characteristics of Symptomatic Pulmonary Thromboembolism among Postoperative and Hospitalized Patients.

Yamamoto N, Unno N, Inuzuka K, Sano M, Saito T, Sugisawa R, Katahashi K, Yata T, Kayama T, Yamanaka Y.

Ann Vasc Dis. 2019 Dec 25;12(4):480-486. doi: 10.3400/avd.oa.19-00125.

25.

Kleptoprotein bioluminescence: Parapriacanthus fish obtain luciferase from ostracod prey.

Bessho-Uehara M, Yamamoto N, Shigenobu S, Mori H, Kuwata K, Oba Y.

Sci Adv. 2020 Jan 8;6(2):eaax4942. doi: 10.1126/sciadv.aax4942. eCollection 2020 Jan.

26.

Ligament Reconstruction for Recurrent Anterior Dislocation of the Radial Head.

Hatta T, Shinagawa K, Hayashi K, Hasegawa K, Miyasaka Y, Yamamoto N, Itoi E.

Case Rep Orthop. 2019 Dec 16;2019:6067312. doi: 10.1155/2019/6067312. eCollection 2019.

27.

Successful percutaneous treatment of recurrent post-infarction ventricular septal rupture using an Amplatzer duct occluder.

Ishiyama M, Kurita T, Ishiura J, Yamamoto N, Sugiura E, Ito H, Tada N, Fujimoto N, Ito M, Dohi K.

J Cardiol Cases. 2019 Sep 25;21(1):12-15. doi: 10.1016/j.jccase.2019.09.003. eCollection 2020 Jan.

28.

Therapies after first-line afatinib in patients with EGFRm+ NSCLC in Japan: retrospective analysis of LUX-Lung 3.

Yoshioka H, Kato T, Okamoto I, Tanaka H, Hida T, Seto T, Kiura K, Tian Y, Azuma H, Yamamoto N.

Future Oncol. 2020 Feb;16(4):49-60. doi: 10.2217/fon-2019-0659. Epub 2020 Jan 10.

29.

Ground-glass opacity as a paradoxical reaction in miliary tuberculosis: A case report and review of the literature.

Tokuyama Y, Matsumoto T, Kusakabe Y, Yamamoto N, Aihara K, Yamaoka S, Mishima M.

IDCases. 2019 Dec 19;19:e00685. doi: 10.1016/j.idcr.2019.e00685. eCollection 2020.

30.

Silicon Nanowires for Intracellular Optical Interrogation with Subcellular Resolution.

Rotenberg MY, Elbaz B, Nair V, Schaumann EN, Yamamoto N, Sarma N, Matino L, Santoro F, Tian B.

Nano Lett. 2020 Feb 12;20(2):1226-1232. doi: 10.1021/acs.nanolett.9b04624. Epub 2020 Jan 9.

PMID:
31904975
31.

Effectiveness of Lifestyle Intervention Using the Internet of Things System for Individuals with Early Type 2 Diabetes Mellitus.

Kato S, Ando M, Honda H, Yoshida Y, Imaizumi T, Yamamoto N, Maruyama S.

Intern Med. 2020;59(1):45-53. doi: 10.2169/internalmedicine.3150-19. Epub 2020 Jan 1.

32.

Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse Model.

Igarashi K, Kawaguchi K, Zhao M, Kiyuna T, Miyake K, Miyake M, Nelson SD, Dry SM, Li Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Higuchi T, Singh SR, Tsuchiya H, Hoffman RM.

Transl Oncol. 2020 Feb;13(2):393-400. doi: 10.1016/j.tranon.2019.10.005. Epub 2019 Dec 30.

33.

Safety and Efficacy of Carbon-ion Radiotherapy Alone for Stage III Non-small Cell Lung Cancer.

Anzai M, Yamamoto N, Hayashi K, Nakajima M, Nomoto A, Ogawa K, Tsuji H.

Anticancer Res. 2020 Jan;40(1):379-386. doi: 10.21873/anticanres.13963.

PMID:
31892590
34.

PPARγ Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model.

Higuchi T, Yamamoto J, Sugisawa N, Tashiro Y, Nishino H, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Cancer Genomics Proteomics. 2020 Jan-Feb;17(1):35-40. doi: 10.21873/cgp.20165.

35.

Impact of the ESM-1 Gene Expression on Outcomes in Stage II/III Gastric Cancer Patients Who Received Adjuvant S-1 Chemotherapy.

Kano K, Sakamaki K, Oue N, Kimura Y, Hashimoto I, Hara K, Maezawa Y, Aoyama T, Fujikawa H, Hiroshima Y, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Cho H, Ito H, Shiozawa M, Yukawa N, Yoshikawa T, Morinaga S, Rino Y, Yasui W, Masuda M, Miyagi Y, Oshima T.

In Vivo. 2020 Jan-Feb;34(1):461-467. doi: 10.21873/invivo.11796.

36.

Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study.

Murakawa M, Yamamoto N, Kamioka Y, Kamiya M, Kobayashi S, Ueno M, Morimoto M, Atsumi Y, Aoyama T, Tamagawa H, Yukawa N, Rino Y, Masuda M, Morinaga S.

In Vivo. 2020 Jan-Feb;34(1):347-353. doi: 10.21873/invivo.11780.

37.

Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: COMPASS (WJOG5610L).

Seto T, Azuma K, Yamanaka T, Sugawara S, Yoshioka H, Wakuda K, Atagi S, Iwamoto Y, Hayashi H, Okamoto I, Saka H, Mitsuoka S, Fujimoto D, Nishino K, Horiike A, Daga H, Sone T, Yamamoto N, Nakagawa K, Nakanishi Y.

J Clin Oncol. 2019 Dec 27:JCO1901494. doi: 10.1200/JCO.19.01494. [Epub ahead of print]

PMID:
31880966
38.

Essential structure of orexin 1 receptor antagonist YNT-707, part V: Structure-activity relationship study of the substituents on the 17-amino group.

Saitoh T, Seki K, Nakajima R, Yamamoto N, Kutsumura N, Nagumo Y, Irukayama-Tomobe Y, Ogawa Y, Ishikawa Y, Yanagisawa M, Nagase H.

Bioorg Med Chem Lett. 2020 Feb 1;30(3):126893. doi: 10.1016/j.bmcl.2019.126893. Epub 2019 Dec 17.

PMID:
31879208
39.

The process of bone regeneration from devitalization to revitalization after pedicle freezing with immunohistochemical and histological examination in rabbits.

Xu G, Yamamoto N, Nojima T, Hayashi K, Takeuchi A, Miwa S, Igarashi K, Tsuchiya H.

Cryobiology. 2019 Dec 22. pii: S0011-2240(19)30289-5. doi: 10.1016/j.cryobiol.2019.12.002. [Epub ahead of print]

40.

[A Case of Pediatric C1 Dysplasia with Ruptured Aneurysm in Collateral Plexiform Arterial Network].

Mizuno A, Haraguchi K, Okada T, Endo O, Fujii K, Takayanagi K, Hiramatsu T, Yamamoto N.

No Shinkei Geka. 2019 Dec;47(12):1261-1267. doi: 10.11477/mf.1436204113. Japanese.

PMID:
31874947
41.

Integrative transcriptome analysis discloses the molecular basis of a heterogeneous fungal phytopathogen complex, Rhizoctonia solani AG-1 subgroups.

Yamamoto N, Wang Y, Lin R, Liang Y, Liu Y, Zhu J, Wang L, Wang S, Liu H, Deng Q, Li S, Li P, Zheng A.

Sci Rep. 2019 Dec 23;9(1):19626. doi: 10.1038/s41598-019-55734-2.

42.

Observational Study of Sequential Afatinib and Osimertinib in EGFR Mutation-Positive NSCLC: Patients Treated with a 40-mg Starting Dose of Afatinib.

Yamamoto N, Mera T, Märten A, Hochmair MJ.

Adv Ther. 2020 Feb;37(2):759-769. doi: 10.1007/s12325-019-01187-y. Epub 2019 Dec 20.

43.

Cathodoluminescence Phase Extraction of the Coupling between Nanoparticles and Surface Plasmon Polaritons.

Sannomiya T, Konečná A, Matsukata T, Thollar Z, Okamoto T, García de Abajo FJ, Yamamoto N.

Nano Lett. 2020 Jan 8;20(1):592-598. doi: 10.1021/acs.nanolett.9b04335. Epub 2019 Dec 24.

PMID:
31855432
44.

Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse model.

Higuchi T, Han Q, Miyake K, Oshiro H, Sugisawa N, Tan Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Biochem Biophys Res Commun. 2020 Feb 26;523(1):135-139. doi: 10.1016/j.bbrc.2019.12.024. Epub 2019 Dec 12.

PMID:
31839218
45.

Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Hashimoto H, Abe M, Tokuyama O, Mizutani H, Uchitomi Y, Yamaguchi T, Hoshina Y, Sakata Y, Takahashi TY, Nakashima K, Nakao M, Takei D, Zenda S, Mizukami K, Iwasa S, Sakurai M, Yamamoto N, Ohe Y.

Lancet Oncol. 2020 Feb;21(2):242-249. doi: 10.1016/S1470-2045(19)30678-3. Epub 2019 Dec 11. Erratum in: Lancet Oncol. 2020 Feb;21(2):e70.

PMID:
31838011
46.

Level of Seven Neuroblastoma-Associated mRNAs Detected by Droplet Digital PCR Is Associated with Tumor Relapse/Regrowth of High-Risk Neuroblastoma Patients.

Thwin KKM, Ishida T, Uemura S, Yamamoto N, Lin KS, Tamura A, Kozaki A, Saito A, Kishimoto K, Mori T, Hasegawa D, Kosaka Y, Nino N, Takafuji S, Iijima K, Nishimura N.

J Mol Diagn. 2020 Feb;22(2):236-246. doi: 10.1016/j.jmoldx.2019.10.012. Epub 2019 Dec 16.

47.

The Correlation of Fluorescence of Protoporphyrinogen IX and Status of Isocitrate Dehydrogenase in Gliomas.

Ohba S, Murayama K, Kuwahara K, Pareira ES, Nakae S, Nishiyama Y, Adachi K, Yamada S, Sasaki H, Yamamoto N, Abe M, Mukherjee J, Hasegawa M, Pieper RO, Hirose Y.

Neurosurgery. 2019 Dec 13. pii: nyz524. doi: 10.1093/neuros/nyz524. [Epub ahead of print]

PMID:
31833548
48.
49.

DNA metabarcoding-based diet survey for the Eurasian otter (Lutra lutra): Development of a Eurasian otter-specific blocking oligonucleotide for 12S rRNA gene sequencing for vertebrates.

Kumari P, Dong K, Eo KY, Lee WS, Kimura J, Yamamoto N.

PLoS One. 2019 Dec 12;14(12):e0226253. doi: 10.1371/journal.pone.0226253. eCollection 2019.

50.

Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors.

Doi T, Matsubara N, Kawai A, Naka N, Takahashi S, Uemura H, Yamamoto N.

Invest New Drugs. 2019 Dec 10. doi: 10.1007/s10637-019-00859-4. [Epub ahead of print]

PMID:
31820255

Supplemental Content

Loading ...
Support Center